Radiolabeled BC8 (anti-CD45) antibody [anti-CD45 monoclonal antibody BC8-I-131] combined with cyclophosphamide and total body irradiation followed by HLA-matched related or unrelated stem cell transplantation as treatment for advanced acute myeloid leukemia and myelodysplastic syndrome.
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2010
At a glance
- Drugs Cyclophosphamide; I-131-Apamistamab; Methotrexate
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 07 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Oct 2005 New trial record.